Heart disease, dementia, diabetes, frailty—what do these seemingly different conditions have in common? Aging. They are distinct diseases with different immediate causes, but age is one of the strongest risk factors for each of them. As we grow older, changes accumulate throughout our cells and tissues, including genomic damage, mitochondrial dysfunction, altered cellular signaling, loss of regenerative capacity, and other forms of biological deterioration. Over time, these changes can increase vulnerability to multiple chronic diseases.
This is why aging matters so much to medicine. Rather than viewing every age-associated disease as an entirely separate problem, we can also examine the underlying biological processes that make the body increasingly susceptible to disease in the first place. Cardiovascular disease, neurodegeneration, metabolic disorders, and frailty may have different clinical manifestations, but they share many of the biological changes associated with aging.
Aging-associated diseases account for a substantial proportion of illness, disability, and mortality worldwide. If we can better understand and safely target the biological processes that drive aging, we may be able to influence multiple diseases at once rather than treating each condition only after it appears. The central question is no longer simply how we treat the diseases of aging, but whether we can intervene in the biology that makes those diseases increasingly likely.
THE BIOVIVA PLATFORM
Our gene therapy development platform assists in
the development of new therapeutics designed to
help patient's cells behave more youthfully
and ward off the degeneration of aging itself
.
Our CMV gene therapy platform supports larger genetic payloads, minimizing the number of treatments patients will need.
THE SCIENCE OF AGING
Your age is your biggest risk factor for disease. Cellular aging is the largest unmet medical need in the world, responsible 63% of death, globally. Right now 15% of Americans are 65 or older. That number is expected to balloon to over 20% by 2050.
From Alzheimer's to cancer, Chronic....
JOIN OUR GENE DATABASE FOR FREE
CodeKeeper™ is BioViva's open access database for gene therapy. It is designed for anyone interested in what is happening in the gene therapy space. Advanced tools are available for universities, companies, independent researchers, and anyone else who is interested in understanding or contributing to the state-of-the-art. Our commitment to open access, open source, and open standards are powerful ideas that have, over the past three decades, repeatedly proven themselves. An increasing number of businesses and organizations are leveraging them to deliver evergreen services.
Learn More
THEY'RE TALKING ABOUT US
